Chengkui Yang

539 total citations
15 papers, 371 citations indexed

About

Chengkui Yang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Chengkui Yang has authored 15 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Chengkui Yang's work include Cell death mechanisms and regulation (8 papers), interferon and immune responses (6 papers) and NF-κB Signaling Pathways (3 papers). Chengkui Yang is often cited by papers focused on Cell death mechanisms and regulation (8 papers), interferon and immune responses (6 papers) and NF-κB Signaling Pathways (3 papers). Chengkui Yang collaborates with scholars based in China, United States and South Korea. Chengkui Yang's co-authors include Sudan He, Zili Zhang, Xiaoliang Yu, Feng Xu, Lu Yu, Xiuxia Zhou, Fang Zhu, Jun Li, Lang Jiang and Tao Yang and has published in prestigious journals such as The Journal of Cell Biology, Biomaterials and Diabetes.

In The Last Decade

Chengkui Yang

14 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chengkui Yang China	10	252	90	51	51	47	15	371
Zbigniew Korwek Poland	11	180 0.7×	109 1.2×	67 1.3×	43 0.8×	56 1.2×	14	398
Chao Nie China	14	310 1.2×	128 1.4×	57 1.1×	51 1.0×	98 2.1×	35	545
Sihao Zheng China	9	273 1.1×	74 0.8×	41 0.8×	30 0.6×	61 1.3×	20	382
Shinya Takazaki Japan	9	311 1.2×	39 0.4×	25 0.5×	34 0.7×	52 1.1×	14	411
Nadeem Mughal United Kingdom	6	167 0.7×	129 1.4×	31 0.6×	35 0.7×	50 1.1×	14	396
Abel Soto-Gamez Netherlands	9	209 0.8×	101 1.1×	50 1.0×	41 0.8×	54 1.1×	15	438
Parvin Ataie-Kachoie Australia	6	137 0.5×	90 1.0×	103 2.0×	51 1.0×	65 1.4×	7	376
Benjamin J. Huang United States	11	224 0.9×	73 0.8×	93 1.8×	17 0.3×	65 1.4×	44	461
Hongwei Pu China	11	135 0.5×	40 0.4×	28 0.5×	67 1.3×	40 0.9×	23	335

Countries citing papers authored by Chengkui Yang

Since Specialization

Citations

This map shows the geographic impact of Chengkui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengkui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengkui Yang more than expected).

Fields of papers citing papers by Chengkui Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengkui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengkui Yang. The network helps show where Chengkui Yang may publish in the future.

Co-authorship network of co-authors of Chengkui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengkui Yang. A scholar is included among the top collaborators of Chengkui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengkui Yang. Chengkui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ji, Yuting, Jingjing Li, Haikuo Ma, et al.. (2025). Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury. Cell Death Discovery. 11(1). 413–413.

Wu, S. C., Xiaoliang Yu, Chengkui Yang, et al.. (2023). Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16. The Journal of Cell Biology. 222(12). 6 indexed citations

Wang, Xinhui, S. C. Wu, Xin Chen, et al.. (2023). Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease. Biochemical Pharmacology. 214. 115647–115647. 7 indexed citations

Yu, Xiaoliang, Yu Han, Liang Li, et al.. (2022). Interferon‐mediated repression of miR ‐324‐5p potentiates necroptosis to facilitate antiviral defense. EMBO Reports. 23(8). e54438–e54438. 9 indexed citations

Yang, Chengkui, Chang Shu, Zhanhui Li, et al.. (2022). Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity. Bioorganic Chemistry. 129. 106051–106051. 2 indexed citations

Li, Zhanhui, Chengkui Yang, Qing Yang, et al.. (2021). Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity. European Journal of Medicinal Chemistry. 228. 114036–114036. 15 indexed citations

Zhu, Fang, Chengkui Yang, S. C. Wu, et al.. (2020). Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury. Frontiers in Cell and Developmental Biology. 8. 606119–606119. 38 indexed citations

Yang, Chengkui, Yifei Zhou, Shan Liu, et al.. (2020). Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis. APOPTOSIS. 25(5-6). 441–455. 16 indexed citations

Wang, Kai, Xiaozhen Dai, Xiaoqing Yan, et al.. (2020). Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis Through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells. Diabetes. 69(8). 1779–1792. 43 indexed citations

10.

Yang, Chengkui, Jun Li, Lu Yu, et al.. (2017). Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death and Disease. 8(10). e3084–e3084. 59 indexed citations

11.

Hu, Zhilin, Bin Song, Lei Xu, et al.. (2016). Aqueous synthesized quantum dots interfere with the NF-κB pathway and confer anti-tumor, anti-viral and anti-inflammatory effects. Biomaterials. 108. 187–196. 39 indexed citations

12.

Yang, Chengkui & Sudan He. (2016). Heat shock protein 90 regulates necroptosis by modulating multiple signaling effectors. Cell Death and Disease. 7(3). e2126–e2126. 26 indexed citations

13.

Liu, Kai, Youli Jian, Xiaojuan Sun, et al.. (2016). Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion. The Journal of Cell Biology. 212(2). 181–198. 59 indexed citations

14.

Yu, Xiaoliang, Yun Li, Qin Chen, et al.. (2015). Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1. Journal of Virology. 90(2). 1088–1095. 32 indexed citations

15.

Kim, Sung‐Hoon, Min Jae Kim, Woo‐Young Seo, et al.. (2012). SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis. Oncogene. 32(35). 4160–4168. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact